[Hereditary hemorrhagic telangiectasia]

Rev Med Interne. 2014 Jan;35(1):21-7. doi: 10.1016/j.revmed.2013.02.022. Epub 2013 Mar 19.
[Article in French]

Abstract

Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) is a development disorder of the vasculature characterized by telangiectases and arteriovenous malformations in specific locations. Among monogenic disorders, it is one of the most common, though affected individuals are widely underdiagnosed. The most common features of this disorder, nosebleeds, and telangiectases on the lips, hands, and oral mucosa are often quite subtle. Mutations in at least five genes may result in hereditary hemorrhagic telangiectasia, but mutations in two genes (ENG and ACVRL1/ALK1) account for approximately 85% of cases. Optimal management requires understanding the specific clinical patterns of these vascular malformations, especially their locations and timing during life. Therapeutic modulation of angiogenesis may be an effective therapy.

Keywords: Angiogenesis; Angiogenèse; Arteriovenous malformations; Hereditary hemorrhagic telangiectasia; Maladie de Rendu-Osler; Malformation artério-veineuse; Monogenic disease; Transmission autosomique dominante; Épistaxis.

Publication types

  • Review

MeSH terms

  • Activin Receptors, Type II / genetics
  • Animals
  • Antigens, CD / genetics
  • Cardiovascular Abnormalities / diagnosis
  • Cardiovascular Abnormalities / epidemiology
  • Cardiovascular Abnormalities / genetics
  • Cardiovascular Abnormalities / therapy
  • Central Nervous System / abnormalities
  • Central Nervous System / blood supply
  • Endoglin
  • Humans
  • Liver / abnormalities
  • Liver / blood supply
  • Lung / abnormalities
  • Lung / blood supply
  • Mutation
  • Receptors, Cell Surface / genetics
  • Smad4 Protein / genetics
  • Telangiectasia, Hereditary Hemorrhagic* / diagnosis
  • Telangiectasia, Hereditary Hemorrhagic* / epidemiology
  • Telangiectasia, Hereditary Hemorrhagic* / genetics
  • Telangiectasia, Hereditary Hemorrhagic* / therapy
  • Viscera / abnormalities
  • Viscera / blood supply

Substances

  • Antigens, CD
  • ENG protein, human
  • Endoglin
  • Receptors, Cell Surface
  • SMAD4 protein, human
  • Smad4 Protein
  • ACVRL1 protein, human
  • Activin Receptors, Type II